Sensory neuropathy induced by anti-TNF-alpha: Study of an observation
El Mandour, Maria
Sensory neuropathy induced by anti-TNF-alpha: Study of an observation - 2025.
17
Anti-TNF-alpha treatments are increasingly widely prescribed. Multiple side effects have been reported in recent years, in particular peripheral neuropathy. We report a case of sensory neuropathy occurring six months after the start of treatment with infliximab. This was in a 43-year-old female patient, followed for APS since 2016, who required treatment with infliximab. Six months later, the patient presented a picture of sensory neuropathy. The etiological workup remained negative, and the discontinuation of infliximab was accompanied by an improvement in symptomatology. The delay between the initiation of infliximab-based treatment and the onset of clinical manifestations, as well as the improvement after dose reduction, argue for the responsibility of infliximab in the occurrence of the sensory neuropathy.
Sensory neuropathy induced by anti-TNF-alpha: Study of an observation - 2025.
17
Anti-TNF-alpha treatments are increasingly widely prescribed. Multiple side effects have been reported in recent years, in particular peripheral neuropathy. We report a case of sensory neuropathy occurring six months after the start of treatment with infliximab. This was in a 43-year-old female patient, followed for APS since 2016, who required treatment with infliximab. Six months later, the patient presented a picture of sensory neuropathy. The etiological workup remained negative, and the discontinuation of infliximab was accompanied by an improvement in symptomatology. The delay between the initiation of infliximab-based treatment and the onset of clinical manifestations, as well as the improvement after dose reduction, argue for the responsibility of infliximab in the occurrence of the sensory neuropathy.
Réseaux sociaux